丸美生物 (603983)

Guangdong Marubi Biotechnology Co., Ltd.

ASH

Tags

DeepSeekSSE 580 IndexPension FundsChemical Raw Materials and Products ManufacturingChemical IndustrySynthetic BiologyIntensive Research CoverageDaily ChemicalsPrivate Enterprises 100 IndexPrivate Equity Heavy PositionsHigh-Performing StocksConcentrated ShareholdingHigh-Dividend Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 40100.00
  • Circulating A-Shares(W): 40100.00
  • Earnings Per Share(RMB): 0.6100
  • Net Assets Per Share(RMB): 8.2880
  • Operating Revenue(W RMB): 245038.05
  • Total Profit(W RMB): 29852.15
  • **Net Profit Attributable to Parent(W RMB) **: 24389.23
  • Net Profit Growth Rate(%): 2.13
  • Weighted Return on Equity(%): 7.1700
  • Operating Cash Flow Per Share(RMB): 0.3960
  • Undistributed Profit Per Share(RMB): 4.8936
  • Capital Reserve Per Share(RMB): 1.8977

2. Main Business

The main business covers:

  • Research, development, design, production, sales and service of various cosmetics

3. Company Basic Information

  • Company Name: Guangdong Marubi Biotechnology Co., Ltd.
  • Listing Date: 2019-07-25
  • Industry: Chemicals - Daily Chemicals
  • Address: 11th Floor, Marubi Building, No. 69 Xingang East Road, Haizhu District, Guangzhou City, Guangdong Province
  • Website: https://www.marubi.cn/
  • Company Profile: Marubi Co., Ltd. was established through the overall transformation of Guangzhou Jiahe. Guangzhou Jiahe used the audited net assets of 94,817,836.04 yuan as of November 30, 2011, as the basis for share conversion, converting at a ratio of 1:0.8437 to form a share capital of 80 million shares (with a par value of 1.00 yuan per share). The remaining net assets balance of 14,817,836.04 yuan after share conversion was recorded as the company's capital reserve. On February 22, 2012, Guangzhou Jiahe completed the change registration at the Guangzhou Administration for Industry and Commerce, transformed into Guangdong Marubi Biotechnology Co., Ltd., and obtained the Business License (Registration No. 440106000253625) with a registered capital of 80 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 CASH Fund - Zhanlin Value Selection 20 Private Securities Investment Fund - CASH Fund Yue Er Hao Single Asset Management Plan Private Securities Investment Fund 1097.66 2.74
2 Fullgoal Consumer Theme Mixed Securities Investment Fund Class A Fund 368.83 0.92
3 Basic Pension Fund 16032 Portfolio Social Security 362.48 0.90
4 Fullgoal Value Creation Mixed Securities Investment Fund Class A Fund 242.65 0.61
5 National Social Security Fund 111 Portfolio Social Security 194.17 0.48
6 China Life Pension Strategy 5 Stock Pension Product - Industrial and Commercial Bank of China Co., Ltd. Asset Management Plan 116.02 0.29
7 Fullgoal Quality Life Mixed Securities Investment Fund Class A Fund 109.33 0.27
8 Fullgoal High Quality Mixed Securities Investment Fund Fund 91.58 0.23
9 Fullgoal Domestic Demand Growth Mixed Securities Investment Fund Class A Fund 75.64 0.19
10 ICBC Credit Suisse New Generation Consumption Flexible Allocation Mixed Securities Investment Fund Fund 39.50 0.10

5. Concept Sectors

  • Synthetic Biology
  • DeepSeek
  • High-Performance Stocks
  • Pension Funds
  • Intensive Research
  • Concentrated Ownership
  • High Dividend Stocks
  • Heavily Held by Private Funds
  • Top 100 Private Enterprises
  • SSE 580

Remarks

  • Data update date: 2025-11-07
  • Data source: Public market information